Regulatory dendritic cells in autoimmunity: A comprehensive review

Journal of Autoimmunity

Volumn 63, Issue , 2015, Pages 1-12

  Liu, Juan ^a   Cao, Xuetao ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Autoimmune diseases; Immune therapy; Immune tolerance; Innate immunity; Regulatory dendritic cells

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BORDETELLA PERTUSSIS; CELL ACTIVATION; CELL MATURATION; CELL MIGRATION; CROSS PRESENTATION; DEACETYLATION; DENDRITIC CELL; EPIGENETICS; GENETIC MANIPULATION; HELICOBACTER PYLORI; HISTONE ACETYLATION; HUMAN; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS REUTERI; MICROENVIRONMENT; MOLECULAR RECOGNITION; MYCOBACTERIUM; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; YERSINIA PESTIS; AUTOIMMUNE DISEASES; IMMUNOLOGY; IMMUNOTHERAPY;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; T-LYMPHOCYTES, REGULATORY;

EID: 84940900743     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.07.011     Document Type: Review

References (158)

1. Steinman R.M., Witmer M.D. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:5132-5136.
2. Schuler G., Steinman R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 1985, 161:526-546.
3. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
4. Qian C., Liu J., Cao X. Innate signaling in the inflammatory immune disorders. Cytokine Growth Factor Rev. 2014, 25:731-773.
5. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003, 21:685-711.
6. Goodnow C.C., Sprent J., Fazekas de St Groth B., Vinuesa C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005, 435:590-597.
7. Pillai S. Rethinking mechanisms of autoimmune pathogenesis. J. Autoimmun. 2013, 45:97-103.
8. Steinman R.M. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 2012, 30:1-22.
9. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000, 192:1213-1222.
10. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001, 193:233-238.
11. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001, 194:769-779.
12. Mahnke K., Qian Y., Knop J., Enk A.H. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003, 101:4862-4869.
13. Yogev N., Frommer F., Lukas D., Kautz-Neu K., Karram K., Ielo D., et al. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity 2012, 37:264-675.
14. Wagner H. Endogenous TLR ligands and autoimmunity. Adv. Immunol. 2006, 91:159-173.
15. Rubartelli A., Lotze M.T. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 2007, 28:429-436.
16. Iwasaki A., Medzhitov R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 2015, 16:343-353.
17. Pulendran B., Tang H., Denning T.L. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr. Opin. Immunol. 2008, 20:61-67.
18. Belz G.T., Nutt S.L. Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol. 2012, 12:101-113.
19. Sathe P., Wu L. The network of cytokines, receptors and transcription factors governing the development of dendritic cell subsets. Protein Cell 2011, 2:620-630.
20. del Rio M.L., Bernhardt G., Rodriguez-Barbosa J.I., Förster R. Development and functional specialization of CD103+ dendritic cells. Immunol. Rev. 2010, 234:268-281.
21. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001, 2:725-731.
22. Coombes J.L., Siddiqui K.R., Arancibia-Cárcamo C.V., Hall J., Sun C.M., Belkaid Y., et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
23. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
24. Guilliams M., Crozat K., Henri S., Tamoutounour S., Grenot P., Devilard E., et al. Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. Blood 2010, 115:1958-1968.
25. Vander Lugt B., Khan A.A., Hackney J.A., Agrawal S., Lesch J., Zhou M., et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat. Immunol. 2014, 15:161-167.
26. Schlitzer A., Sivakamasundari V., Chen J., Sumatoh H.R., Schreuder J., Lum J., et al. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow. Nat. Immunol. 2015, 16:718-728.
27. Grajales-Reyes G.E., Iwata A., Albring J., Wu X., Tussiwand R., Kc W., et al. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor. Nat. Immunol. 2015, 16708-16717.
28. Shortman K., Heath W.R. The CD8+ dendritic cell subset. Immunol. Rev. 2010, 234:18-31.
29. Osorio F., Tavernier S.J., Hoffmann E., Saeys Y., Martens L., Vetters J., et al. The unfolded-protein-response sensor IRE-1α regulates the function of CD8α+ dendritic cells. Nat. Immunol 2014, 15:248-257.
30. Belz G.T., Behrens G.M., Smith C.M., Miller J.F., Jones C., Lejon K., et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 2002, 196:1099-1104.
31. Yamazaki S., Dudziak D., Heidkamp G.F., Fiorese C., Bonito A.J., Inaba K., et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 2008, 181:6923-6933.
32. Proietto A.I., van Dommelen S., Zhou P., Rizzitelli A., D'Amico A., Steptoe R.J., et al. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19869-19874.
33. Watanabe N., Wang Y.H., Lee H.K., Ito T., Wang Y.H., Cao W., et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005, 436:1181-1185.
34. Weist B.M., Kurd N., Boussier J., Chan S.W., Robey E.A. Thymic regulatory T cell niche size is dictated by limiting IL-2 from antigen-bearing dendritic cells and feedback competition. Nat. Immunol. 2015, 16:635-641.
35. Gallegos A.M., Bevan M.J. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 2004, 200:1039-1049.
36. McCaughtry T.M., Baldwin T.A., Wilken M.S., Hogquist K.A. Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla. J. Exp. Med. 2008, 205:2575-2584.
37. Bonasio R., Scimone M.L., Schaerli P., Grabie N., Lichtman A.H., von Andrian U.H. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol. 2006, 7:1092-1100.
38. Jongbloed S.L., Kassianos A.J., McDonald K.J., Clark G.J., Ju X., Angel C.E., et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 2010, 207:1247-1260.
39. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23:275-306.
40. Reizis B., Bunin A., Ghosh H.S., Lewis K.L., Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 2011, 29:163-183.
41. Moseman E.A., Liang X., Dawson A.J., Panoskaltsis-Mortari A., Krieg A.M., Liu Y.J., et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 2004, 173:4433-4442.
42. Fallarino F., Asselin-Paturel C., Vacca C., Bianchi R., Gizzi S., Fioretti M.C., et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 2004, 173:3748-3754.
43. Gilliet M., Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 2002, 195:695-704.
44. Chen W., Liang X., Peterson A.J., Munn D.H., Blazar B.R. The indoleamine 2, 3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory Cell generation. J. Immunol. 2008, 181:5396-5404.
45. Ito T., Yang M., Wang Y.H., Lande R., Gregorio J., Perng O.A., et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007, 204:105-115.
46. Jahrsdörfer B., Vollmer A., Blackwell S.E., Maier J., Sontheimer K., Beyer T., et al. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 2010, 115:1156-1165.
47. Munn D.H., Sharma M.D., Lee J.R., Jhaver K.G., Johnson T.S., Keskin D.B., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002, 297:1867-1870.
48. Mellor A.L., Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol 2004, 4:762-774.
49. Martín-Gayo E., Sierra-Filardi E., Corbí A.L., Toribio M.L. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 2010, 115:5366-5375.
50. Goubier A., Dubois B., Gheit H., Joubert G., Villard-Truc F., Asselin-Paturel C., et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008, 29:464-475.
51. Watkins S.K., Zhu Z., Riboldi E., Shafer-Weaver K.A., Stagliano K.E., Sklavos M.M., et al. FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J. Clin. Invest 2015, 125:2179.
52. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., Butcher E.C. CCR9 expression defines tolerogenicplasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 2008, 9:1253-1260.
53. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
54. Morelli A.E., Thomson A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007, 7:610-621.
55. Manicassamy S., Pulendran B. Dendritic cell control of tolerogenic responses. Immunol. Rev. 2011, 241:206-227.
56. Zhang M., Tang H., Guo Z., An H., Zhu X., Song W., et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat. Immunol. 2004, 5:1124-1133.
57. Tang H., Guo Z., Zhang M., Wang J., Chen G., Cao X. Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10. Blood 2006, 108:1189-1197.
58. Xia S., Guo Z., Xu X., Yi H., Wang Q., Cao X. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood 2008, 112:3175-3185.
59. Li Q., Guo Z., Xu X., Xia S., Cao X. Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflammation. Eur. J. Immunol. 2008, 38:2751-2761.
60. Liu Q., Zhang C., Sun A., Zheng Y., Wang L., Cao X. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I. J. Immunol. 2009, 182:6207-6216.
61. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003, 18:605-617.
62. Svensson M., Maroof A., Ato M., Kaye P.M. Stromal cells direct local differentiation of regulatory dendritic cells. Immunity 2004, 21:805-816.
63. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8:411-420.
64. Liu Y.J., Soumelis V., Watanabe N., Ito T., Wang Y.H., MalefytRde W., et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol. 2007, 25:193-219.
65. Iliev I.D., Spadoni I., Mileti E., Matteoli G., Sonzogni A., Sampietro G.M., et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009, 58:1481-1489.
66. McDole J.R., Wheeler L.W., McDonald K.G., Wang B., Konjufca V., Knoop K.A., et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 2012, 483:345-349.
67. Manicassamy S., Reizis B., Ravindran R., Nakaya H., Salazar-Gonzalez R.M., Wang Y.C., et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010, 329:849-853.
68. Min W.P., Zhou D., Ichim T.E., Strejan G.H., Xia X., Yang J., et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J. Immunol. 2003, 170:1304-1312.
69. Cederbom L., Hall H., Ivars F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 2000, 30:1538-1543.
70. Veldhoen M., Moncrieffe H., Hocking R.J., Atkins C.J., Stockinger B. Modulation of dendritic cell function by naive and regulatory CD4+ T cells. J. Immunol. 2006, 176:6202-6210.
71. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 2002, 3:1097-1101.
72. Darrasse-Jèze G., Deroubaix S., Mouquet H., Victora G.D., Eisenreich T., Yao K.H., et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 2009, 206:1853-1862.
73. Caielli S., Conforti-Andreoni C., Di Pietro C., Usuelli V., Badami E., Malosio M.L., et al. On/off TLR signaling decides proinflammatory or tolerogenic dendritic cell maturation upon CD1d-mediated interaction with invariant NKT cells. J. Immunol. 2010, 185:7317-7329.
74. Caielli S., Sorini C., Falcone M. The dangerous liaison between iNKT cells and dendritic cells: does it prevent or promote autoimmune diseases?. Autoimmunity 2011, 44:11-22.
75. Peng Y., Martin D.A., Kenkel J., Zhang K., Ogden C.A., Elkon K.B. Innate and adaptive immune response to apoptotic cells. J. Autoimmun. 2007, 29:303-309.
76. Devitt A., Marshall L.J. The innate immune system and the clearance of apoptotic cells. J. Leukoc. Biol. 2011, 90:447-457.
77. Krysko D.V., D'Herde K., Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 2006, 11:1709-1726.
78. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997, 390:350-351.
79. Stuart L.M., Lucas M., Simpson C., Lamb J., Savill J., Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J. Immunol. 2002, 168:1627-1635.
80. Wallet M.A., Sen P., Flores R.R., Wang Y., Yi Z., Huang Y., et al. MerTK is required for apoptotic cell-induced T cell tolerance. J. Exp. Med. 2008, 205:219-232.
81. Binder R.J., Srivastava P.K. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat. Immunol. 2005, 6:593-599.
82. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8:279-289.
83. Morelli A.E., Thomson A.W. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 2003, 196:125-146.
84. Hackstein H., Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 2004, 4:24-34.
85. Manicassamy S., Ravindran R., Deng J., Oluoch H., Denning T.L., Kasturi S.P., et al. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat. Med. 2009, 15:401-409.
86. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning T.L., Oswald-Richter K., et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest 2006, 116:916-928.
87. Depaolo R.W., Tang F., Kim I., Han M., Levin N., Ciletti N., et al. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 2008, 4:350-361.
88. van der Kleij D., Latz E., Brouwers J.F., Kruize Y.C., Schmitz M., Kurt-Jones E.A., et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 2002, 277:48122-48129.
89. McGuirk P., McCann C., Mills K.H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 2002, 195:221-231.
90. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 2005, 115:1260-1267.
91. Geijtenbeek T.B., Van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M., Appelmelk B., et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 2003, 197:7-17.
92. Bergman M.P., Engering A., Smits H.H., van Vliet S.J., van Bodegraven A.A., Wirth H.P., et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 2004, 200:979-990.
93. Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F., et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19474-19479.
94. Ravetch J.V., Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 2001, 19:275-290.
95. Samsom J.N., van Berkel L.A., van Helvoort J.M., Unger W.W., Jansen W., Thepen T., et al. Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells. J. Immunol. 2005, 174:5279-5287.
96. Desai D.D., Harbers S.O., Flores M., Colonna L., Downie M.P., Bergtold A., et al. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J. Immunol. 2007, 178:6217-6226.
97. Wenink M.H., Santegoets K.C., Roelofs M.F., Huijbens R., Koenen H.J., van Beek R., et al. The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease. J. Immunol. 2009, 183:4509-4520.
98. Zhang Y., Liu S., Yu Y., Zhang T., Liu J., Shen Q., et al. Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus. Eur. J. Immunol. 2011, 41:1154-1164.
99. Portela A., Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010, 28:1057-1068.
100. HP1 Kim, Lee Y.S., Park J.H., Kim Y.J. Transcriptional and epigenetic networks in the development and maturation of dendritic cells. Epigenomics 2013, 5:195-204.
101. Nencioni A., Beck J., Werth D., Grünebach F., Patrone F., Ballestrero A., et al. Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clin. Cancer Res. 2007, 13:3933-3941.
102. Roger T., Lugrin J., Le Roy D., Goy G., Mombelli M., Koessler T., et al. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 2011, 117:1205-1217.
103. Villagra A., Cheng F., Wang H.W., Suarez I., Glozak M., Maurin M., et al. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat. Immunol. 2009, 10:92-100.
104. Cheng F., Lienlaf M., Wang H.W., Perez-Villarroel P., Lee C., Woan K., et al. A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs. J. Immunol. 2014, 193:2850-2862.
105. Dunand-Sauthier I., Santiago-Raber M.L., Capponi L., Vejnar C.E., Schaad O., Irla M., et al. Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. Blood 2011, 117:4490-4500.
106. Ceppi M., Pereira P.M., Dunand-Sauthier I., Barras E., Reith W., Santos M.A., et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2735-2740.
107. Min S., Li L., Zhang M., Zhang Y., Liang X., Xie Y., et al. TGF-β-associated miR-27a inhibits dendritic cell-mediated differentiation of Th1 and Th17 cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7. Genes Immun. 2012, 13:621-631.
108. X. Liu, Z. Zhan, L. Xu, F. Ma, D. Li, Z. Guo, et al., MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα, J. Immunol. 185 7244-7251.
109. Li H.S., Greeley N., Sugimoto N., Liu Y.J., Watowich S.S. miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. PLoS One 2012, 7(12):e52341.
110. Bai Y., Qian C., Qian L., Ma F., Hou J., Chen Y., et al. Integrin CD11b negatively regulates TLR9-triggered dendritic cell cross-priming by upregulating microRNA-146a. J. Immunol. 2012, 188:5293-5302.
111. Su X., Qian C., Zhang Q., Hou J., Gu Y., Han Y., et al. miRNomes of haematopoietic stem cells and dendritic cells identify miR-30b as a regulator of Notch1. Nat. Commun. 2013, 4:2903.
112. Carpenter S., Aiello D., Atianand M.K., Ricci E.P., Gandhi P., Hall L.L., et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 2013, 341:789-792.
113. Rapicavoli N.A., Qu K., Zhang J., Mikhail M., Laberge R.M., Chang H.Y. A mammalian pseudogenelncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife 2013, 2:e00762.
114. Li Z., Chao T.C., Chang K.Y., Lin N., Patil V.S., Shimizu C., et al. The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:1002-1007.
115. Wang P., Xue Y., Han Y., Lin L., Wu C., Xu S., et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science 2014, 344:310-313.
116. Travis M.A., Reizis B., Melton A.C., Masteller E., Tang Q., Proctor J.M., et al. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007, 449:361-365.
117. Fujikado N., Saijo S., Yonezawa T., Shimamori K., Ishii A., Sugai S., et al. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 2008, 14:176-180.
118. Stranges P.B., Watson J., Cooper C.J., Choisy-Rossi C.M., Stonebraker A.C., Beighton R.A., et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 2007, 26:629-641.
119. Fields M.L., Sokol C.L., Eaton-Bassiri A., Seo S., Madaio M.P., Erikson J. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J. Immunol. 2001, 167:2370-2378.
120. Kool M., van Loo G., Waelput W., De Prijck S., Muskens F., Sze M., et al. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 2011, 35:82-96.
121. Hammer G.E., Turer E.E., Taylor K.E., Fang C.J., Advincula R., Oshima S., et al. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat. Immunol. 2011, 12:1184-1193.
122. Kaneko T., Saito Y., Kotani T., Okazawa H., Iwamura H., Sato-Hashimoto M., et al. Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity. J. Immunol. 2012, 188:5397-5407.
123. Lin A.E., Ebert G., Ow Y., Preston S.P., Toe J.G., Cooney J.P., et al. ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune system. Nat. Immunol. 2013, 14:27-33.
124. Liu J., Han C., Xie B., Wu Y., Liu S., Chen K., et al. Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO. Nat. Immunol. 2014, 15:612-622.
125. Melillo J.A., Song L., Bhagat G., Blazquez A.B., Plumlee C.R., Lee C., et al. Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J. Immunol. 2010, 184:2638-2645.
126. Kim S.J., Zou Y.R., Goldstein J., Reizis B., Diamond B. Tolerogenic function of Blimp-1 in dendritic cells. J. Exp. Med. 2011, 208:2193-2199.
127. Zhao J., Brooks D.M., Lurie D.I. Lipopolysaccharide-activated SHP-1-deficient motheaten microglia release increased nitric oxide, TNF-alpha, and IL-1beta. Glia 2006, 53:304-312.
128. Hardin A.O., Meals E.A., Yi T., Knapp K.M., English B.K. SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages. Biochem. Biophys. Res. Commun. 2006, 342:547-555.
129. An H., Hou J., Zhou J., Zhao W., Xu H., Zheng Y., et al. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 2008, 9:542-550.
130. Ganguly D., Haak S., Sisirak V., Reizis B. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 2013, 13:566-577.
131. Ohnmacht C., Pullner A., King S.B., Drexler I., Meier S., Brocker T., et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 2009, 206:549-559.
132. Lang K.S., Burow A., Kurrer M., Lang P.A., Recher M. The role of the innate immune response in autoimmune disease. J. Autoimmun. 2007, 29:206-212.
133. O'Shea J.J., Ma A., Lipsky P. Cytokines and autoimmunity. Nat. Rev. Immunol. 2002, 2:37-45.
134. Lleo A., Selmi C., Invernizzi P., Podda M., Gershwin M.E. The consequences of apoptosis in autoimmunity. J. Autoimmun. 2008, 31:257-262.
135. Chen M., Wang Y.H., Wang Y., Huang L., Sandoval H., Liu Y.J., et al. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 2006, 311:1160-1164.
136. Schett G., Elewaut D., McInnes I.B., Dayer J.M., Neurath M.F. How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy. Nat. Med. 2013, 19:822-824.
137. Amodio G., Gregori S. Dendritic cells a double-edge sword in autoimmune responses. Front. Immunol. 2012, 3:233.
138. Thomas R. Dendritic cells as targets or therapeutics in rheumatic autoimmune disease. Curr. Opin. Rheumatol. 2014, 26:211-218.
139. Maloy K.J., Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474:298-306.
140. Pierik M., Joossens S., Van Steen K., Van Schuerbeek N., Vlietinck R., Rutgeerts P., et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 2006, 12:1-8.
141. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cézard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
142. Maeda S., Hsu L.C., Liu H., Bankston L.A., Iimura M., Kagnoff M.F., et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005, 307:734-738.
143. Richardson W.M., Sodhi C.P., Russo A., Siggers R.H., Afrazi A., Gribar S.C., et al. Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium. Gastroenterology 2010, 139:904-917.
144. R. Cooney, J. Baker, O. Brain, B. Danis, T. Pichulik, P. Allan, et al., NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation, Nat. Med. 16 90-97.
145. Travassos L.H., Carneiro L.A., Ramjeet M., Hussey S., Kim Y.G., Magalhães J.G., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 2010, 11:55-62.
146. Saitoh T., Fujita N., Jang M.H., Uematsu S., Yang B.G., Satoh T., et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008, 456:264-268.
147. Gonzalez-Rey E., Delgado M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology 2006, 131:1799-1811.
148. Pedersen A.E., Schmidt E.G., Gad M., Poulsen S.S., Claesson M.H., et al. Dexamethasone/1alpha-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model. Immunology 2009, 127:354-364.
149. Pedersen A.E., Gad M., Kristensen N.N., Haase C., Nielsen C.H., Claesson M.H. Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer model. Immunology 2007, 121:526-532.
150. Kassianos A.J., Hardy M.Y., Ju X., Vijayan D., Ding Y., Vulink A.J., et al. Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli. Eur. J. Immunol. 2012, 42:1512-1522.
151. Qian C., Cao X. Naturally occurring CD1c+ human regulatory dendritic cells: immunoregulators that are expanded in response to E. coli infection. Eur. J. Immunol. 2012, 42:1388-1392.
152. Bamboat Z.M., Stableford J.A., Plitas G., Burt B.M., Nguyen H.M., Welles A.P., et al. Human liver dendritic cells promote T cell hyporesponsiveness. J. Immunol. 2009, 182:1901-1911.
153. Chu C.C., Ali N., Karagiannis P., Di Meglio P., Skowera A., Napolitano L., et al. Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J. Exp. Med. 2012, 209:935-9345.
154. Han Y., Chen Z., Yang Y., Jiang Z., Gu Y., Liu Y., et al. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma. Hepatology 2014, 59:567-579.
155. Raïch-Regué D., Grau-López L., Naranjo-Gómez M., Ramo-Tello C., Pujol-Borrell R., Martínez-Cáceres E., et al. Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. Eur. J. Immunol. 2012, 42:771-782.
156. Harry R.A., Anderson A.E., Isaacs J.D., Hilkens C.M., et al. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69:2042-2050.
157. Giannoukakis N., Phillips B., Finegold D., Harnaha J., Trucco M. Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011, 34:2026-2032.
158. Hilkens C.M., Isaacs J.D. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?. Clin. Exp. Immunol. 2013, 172:148-157.